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Enzyme Replacement Therapy 
Yarosh et al (p. 461) demonstrate that T4Ns liposomes can pene-
trate into the epidermis and deliver an encapsulated enzyme into the 
cells in mouse skin. This bioengineering strategy, related to gene 
therapy, is designed to deliver enzymes to the skin to replace or 
enhance cellular functions . T4Ns liposome is just such a replace-
ment therapy. These multilamellar lipid vesicles are designed to 
deliver the DNA repair enzyme T4 endonuclease V into the skin to 
enhance repair of ultraviolet damage from sunlight. Previously, the 
liposomes have been shown to enhance repair in ultraviolet (UV)-
irradiated explants of human skin U [n"est Dermatol 97:147 -150, 
1991), prevent UV -induced systemic immunosuppression in mice, 
and stimulate melanogenesis after UV U lIlVest Dermatoll0l:666-
672, 1993). Using fluorescent markers in the liposome membrane 
to track the liposomes, Yarosh et al find that after topical applica-
tion, liposomes penetrate through the stratum corneum, localize in 
the epidermis, particularly the hair follicles, and lodge in basal kera-
tinocytes, and that in "itro the liposomes are internalized by kerati-
nocytes. The authors find the enzyme present in both the cytoplasm 
and nucleus ofkeratinocytes and Langerhans cells in the skin, and in 
cells of the lymph nodes draining sites of contact sensitization. 
These results indicate that the T4Ns liposome system can deliver 
enzyme to the epidermis and its appendages with little enzyme 
appearing in the dermis, thereby reducing systemic delivery and the 
risk of adverse side effects. 
Aberrant Expression of KGF in Delayed Wound Healing 
Werner et al (p. 469) show that expression of keratinocyte growth 
factor (KGF) is reduced and delayed in genetically diabetic (db/db) 
mice. These mice show the typical characteristics of obesity, insulin 
resistance, and severe hypoglycemia seen in the onset of adult 
human diabetes mellitus. In addition , these mice show a marked 
delay in healing wounds in their skin. Previously, it was shown that 
topical application of fibroblast growth factors (FGFs) to wounds 
produced a beneficial effect, suggesting a role for endogenous FGF 
in -wound repair. The FGF fami ly includes at least nine different 
polypeptides that stimulate mitogenesis and chemotaxis in several 
cells from epithelial and mesenchymal tissues. Thus, these family 
members have the properties expected of wound cytokines. Re-
cently, Werner et al determined that several members of the FGF 
family were induced during the healing of full-thickness wounds in 
normal mice. Specifically, keratinocyte growth factor (also known 
as FGF-7) was induced more than 160-fold in the fibroblasts at the 
wound edge within twenty-four hours after wounding. This sug-
gests that KGF, a highly specific mitogen for keratinocytes, stimu-
lates re-epithelialization of the wound in a paracrine manner. To 
determine whether wound-healing disorders, such as those seen in 
diabetes, are associated with a defect in growth-factor regulation, 
Werner et al investigated the expression of these mitogens in 
wounded and unwounded skin of the genetically diabetic (db/db) 
mice. They demonstrate that the induction of KGF is reduced and 
delayed, and that acidic and basic FGFs are altered in these mice 
during the period when re-epithelialization and granulation tissue 
formation should be occurring. Thus, these growth factors are lim-
ited during wound healing in these animals, suggesting that the 
aberrant expression of endogenous FGFs may be partially responsi-
ble for the wound healing defect seen in db/db mice. 
0022-202Xj94jS07.00 Copyright © 1994 by The Society for Investigative Dermatology, Inc. 
459 
460 IN THIS ISSUE THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
Two Types of Ereaks in Epidermal Integrity 
One of the most important characteristics of skin is its mechanical 
strength; specifically, the epidermis must withstand the sheering 
forces exerted when it is rubbed across harder objects. When cells in 
the epidermis have defective genes, the epidermis may not retain the 
strength necessary to held itself together under stress. This loss of 
integrity can occur either between the epidermal cells or within the 
cells themselves. This is what happens in the two diseases reported 
in this issue. The first disease, Darier disease, is characterized by a 
loss of epidermal cell cohesion resulting in hyperkeratotic skin pap-
ules and disordered keratinization and, although this disease is char-
acterized by cell dissociation, no link to mutation in genes for des-
mosomes have been found. Ikeda et al (p. 478) examine skin 
specimens from ten families of European and Middle Eastern ances-
try who show clinical manifestations of the autosomal dominant 
skin disease Darier disease. Their findings agree with previously 
reported results that the underlying mutation for this disease is 
localized to chromosome 12q, a site clearly distal to the keratin gene 
cluster on this chromosome, and thus this disease is not caused by a 
keratin gene mutation. In addition, they show evidence for subloca-
lization to a specific region on chromosome 12q, thereby narrowing 
the area where the specific mutation must be localized. The second 
disease, palmoplantar epidermoltyic hyperkeratosis, is distinctly 
different in that the spinous cells break apart because of a defect in 
the structural filamentous network. The underlying defect is 
known in this disease to be produced by a mutation in the keratin 9 
gene. Bonifas et al (p. 474) examine two families with the specific 
epidermolytic hyperkeratotic skin disease affecting only the palms 
and soles of the feet. Their findings agree with previous reports that 
this disease is caused by mutations encoding keratin 9, a molecule 
expressed only in the suprabasal cells of the epidermis of palms and 
soles of the feet . 
Cutaneous Matrix Remodeling During Development, Wound Healing, and Neoplasia 
In this issue, two groups report on a distinct class of extracellular 
matrix proteinases, the metalloproteinase family . These protcinases, 
produced primarily by tissue stromal cells, are essential for connec-
tive tissue remodeling and localized degradation of the extracellular 
matrix necessary for cell migration. Karelina et al (p. 482) lind that 
matrilysin, a unique member of the metalloproteinase family, is 
expressed by epidermal cells at the base~ent. membrane junction of 
invading appendagel and tumor cells. Stncklm and Nanney (p. 488) 
find that both immunoreactive collagenase and members of the 
tissue inhibitors of metalloproteinase (TIMP) family are increased 
during wound healing, specifically in the interface zones between 
eschar and viable dermis, resurfacing epidermis and dermis, and at 
the boundaries of dermis and blood vessels, hair follicles, and sweat 
ducts. Using immunohistochemistry to examine human burn 
wounds, they find collagenase and TIMP rapidly secreted into the 
extracellular matrix of the wound bed and subsequently localized at 
the epidermal-dermal junctions in the wounds, but not in adjacent 
regions of normal skin. This work demonstrates that the specific 
distribution of the proteolytic and inhibitory forces within the 
wound is focussed at the epidermal-dermal interfaces and thus, 
likely provides the tissue fluidity necessary for proper repair. In 
examining human fetal skin and human skin tumors, Karelina et af 
find similar results. Human skin requires the production, deposi-
tion, assembly, and turnover of extracellular matrix molecules to 
maintain normal tissue architecture and form new architecture dur-
ing development. Karelina et af show that matrilysin is localized 
intracellularly in areas of the epithelium where cells must grow into 
the mesenchyme. For example, in developing hair buds, when the 
budding epithelium begins its downward growth into the mesen-
chyme, all cells within the buds express matrilysin. As development 
progresses, matrilysin is concentrated only within the cells at t~e 
distal portion of the invading hair follicle and sweat gland. In skIn 
tumors, Karelina et af find that matrilysin is strategically located at 
the tumor-stromal interface of the more aggressive basal cell and 
squamous cell carcinomas. The findings of these two groups suggest 
that enzymes from the metalloproteinase family play important 
roles in cell migration during wound healing, appendageal develop-
ment, and tumor invasion. 
Induction of p53 Protein and mRNA 
Healy et af (p. 493) show that suberythemal doses ofUVB radiation 
cause p53 protein to accumula.t~ in human skin without changing 
the level of p53 mRNA. In addition, they show that a variety of skin 
irritants also cause an increase in p53 protein in the skin; however, in 
contrast to UV radiation, skin irritation is accompanied by an in-
crease in the level of p53 mRNA. The p53 gene codes for a phos-
phoprotein that appears to playa major role in preventing the devel-
opment of cancer: firstly, inactivation of the p53 gene is the most 
common genetic abnormality described in human cancer, including 
non-melanoma skin cancer in which a p53 gene mutation is a com-
mon and early event; and secondly, transgenic mice null for p53 and 
humans who inherit a germ-line mutation of the p53 gene show an 
increase in cancer incidence. UV exposure to skin exerts a variety of 
effects on human skin including acute and delayed erythema, im-
mediate and delayed tanning, and proliferative responses. In addi-
tion, UV can cause somatic mutations in the p53 tumor-suppressor 
gene. The exposure to DNA damaging agents causes accumulation 
of the p53 protein secondary to stabilization of the protein, which in 
turn leads to transactivation of genes involved in growth arrest and 
apoptosis. This is demonstrated by the increase of p53 protein in 
human skin after UV exposure. Healy et af demonstrate that even a 
low dose ofUVB can have a significant impact on molecular home-
ostasis by showing that p53 protein elevation is not directly related 
to skin erythema. Additionally, the induction of p53 mRNA by skin 
irritants, but not by UVR, suggests that the various stimuli may 
increase p53 protein in vivo by different mechanisms. 
